ArticleBMC chemistry2025
Enhancing antibiotic detection via an aptasensor: the case of ciprofloxacin.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bimetallic urchin-like Au@Pt/SiOMikrochimica acta · 2026Article
- Biomimetic Carbon-Based Nanomaterials: From Design Strategies to Next-Generation Biosensing and Theranostic Applications.Small (Weinheim an der Bergstrasse, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The need for fast, efficient, and cost-effective test systems for antibiotics is surging, to control resistant bacterial strains. Electrochemical biosensors offer a good alternative to routine laboratory-bound analytical methods. These biosensors are portable, suitable for in-field analysis and biocompatible for detection of small biomolecules. The aim of this work is the ciprofloxacin active pharmaceutical ingredient since resistance of bacteria to this antibiotic is reportedly increasing worldwide, especially in Lebanon where hospitalization bills are no longer affordable. So, the target is ciprofloxacin detection, a fluoroquinolone antibiotic, on screen-printed electrodes. Following diazonium salt, also known as carboxymethylaniline (CMA) deposition, a ciprofloxacin oligonucleotide was incubated on the electrode. This aptamer acts as an anchor for the ciprofloxacin molecule, allowing the latter's attachment to the electrode and its quantification. Electrochemical characterization, through cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) allowed for deposition of molecules on electrodes and confirmation that an electrochemical change took place. Scanning Electron Microscope images are used to confirm conformational changes on the surface of electrodes. Impedance results reported a limit of detection of LOD = 3 nM, a dynamic range from 10 nM to 100 µM, and reproducibility of results between two aptasensors to be 10%. Moreover, impedimetric sensor specificity evaluation was through the effect of interfering compounds tobramycin, ofloxacin, norfloxacin and ceftriaxone, on the aptasensor's response. Based on available literature, this LOD level reached allows for the detection of ciprofloxacin via a portable potentiostat in environmental (wastewater, food), biological (urine, saliva) and pharmaceutical samples (efficient market withdrawal of counterfeit medications from pharmaceutical storage facilities).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.